CorMedix (CRMD) EBITDA (2010 - 2026)
CorMedix (CRMD) posted EBITDA of $59.1 million for Q4 2025, up 15.15% sequentially from $51.3 million in Q3 2025, and up 357.05% YoY from $12.9 million in Q4 2024.
CorMedix (CRMD) EBITDA (2010 - 2026) Analysis & Trends
CorMedix has reported EBITDA for 16 years, with the latest figure at $59.1 million in Q4 2025.
- Quarterly EBITDA rose 357.05% year-over-year to $59.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150.1 million (up 771.59% YoY) and the FY2025 annual result came in at $150.1 million, up 771.59% from the prior year.
- EBITDA improved to $59.1 million in Q4 2025 per CRMD's latest filing, from $51.3 million in the prior quarter.
- Over five years, EBITDA peaked at $59.1 million in Q4 2025 and troughed at -$16.7 million in Q1 2024.
- A 5-year average of $938282.8 and a median of -$7.5 million in 2021 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA plunged 86.77% in 2023, then jumped 1661.93% in 2025.
- Over 5 years, EBITDA stood at -$7.8 million in 2021, then retreated by 7.83% to -$8.4 million in 2022, then tumbled by 86.77% to -$15.7 million in 2023, then surged by 182.56% to $12.9 million in 2024, then surged by 357.05% to $59.1 million in 2025.
- According to Business Quant data, EBITDA over the past three periods registered $59.1 million, $51.3 million, and $19.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 42.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.91 Mn |
| Dec 31, 2025 | 59.13 Mn |
| Sep 30, 2025 | 51.35 Mn |
| Jun 30, 2025 | 19.54 Mn |
| Mar 31, 2025 | 20.13 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Sep 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -15.30 Mn |
| Mar 31, 2024 | -16.70 Mn |
| Dec 31, 2023 | -15.67 Mn |
| Sep 30, 2023 | -10.47 Mn |
| Jun 30, 2023 | -11.80 Mn |
| Mar 31, 2023 | -11.02 Mn |
| Dec 31, 2022 | -8.39 Mn |
| Sep 30, 2022 | -6.96 Mn |
| Jun 30, 2022 | -8.24 Mn |
| Mar 31, 2022 | -7.03 Mn |
| Dec 31, 2021 | -7.78 Mn |
| Sep 30, 2021 | -8.56 Mn |
| Jun 30, 2021 | -5.88 Mn |